Fulcrum Therapeutics Cash from Operations (Quarterly) Trends

Fulcrum Therapeutics Inc (FULC)

3.315 +0.06 (+1.69%) USD | NASDAQ | Nov 05, 16:00

3.315 0.00 (0.00%) After-Hours: 16:00

Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
June 30, 2024	58.90M
March 31, 2024	-25.28M
December 31, 2023	-23.16M
September 30, 2023	-22.91M
June 30, 2023	-20.78M
March 31, 2023	-24.12M
December 31, 2022	-19.70M
September 30, 2022	-27.88M
June 30, 2022	-27.37M
March 31, 2022	-22.11M
December 31, 2021	-21.86M
September 30, 2021	-22.57M
June 30, 2021	-17.82M

Date	Value
March 31, 2021	-16.23M
December 31, 2020	-19.83M
September 30, 2020	-4.504M
June 30, 2020	-14.12M
March 31, 2020	-15.20M
December 31, 2019	-4.495M
September 30, 2019	-13.02M
June 30, 2019	-12.07M
March 31, 2019	-9.897M
December 31, 2018	-6.403M
September 30, 2018	-4.12M
June 30, 2018	-5.407M
March 31, 2018	-6.632M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

-27.88M

Minimum

Sep 2022

58.90M

Maximum

Jun 2024

-15.32M

Average

-20.78M

Median

Jun 2023

Cash from Operations (Quarterly) Benchmarks

Bioventus Inc	15.16M
Arcturus Therapeutics Holdings Inc	-30.14M
Entrada Therapeutics Inc	39.83M
Johnson & Johnson	7.993B
Insmed Inc	-180.92M

Cash from Operations (Quarterly) Related Metrics

Cash from Investing (Quarterly)	-12.51M
Cash from Financing (Quarterly)	0.377M
Free Cash Flow	-12.62M
Free Cash Flow Per Share (Quarterly)	0.9263
Free Cash Flow to Equity (Quarterly)	58.90M
Free Cash Flow Yield	-6.11%